Allarity Therapeutics Inc
ALLR
Get informed when a big investor buys or sells
+ FollowMarket Cap$26.09M
Close$
$1.21
23.4% downside
Current Fair Value
23.4% downsideOvervalued by 23.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $26.09 Million |
|---|---|
| Enterprise Value | $6.36 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.78 |
| Beta | 0.38 |
| Outstanding Shares | 15,968,591 |
Return
| Return on Equity | -0.26% |
|---|---|
| Return on Assets | -0.05% |
| Return on Invested Capital | -153.76% |
Valuation & Multiples
| P/E Ratio | -2.33 |
|---|---|
| PEG | -353.35 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 18.44 |
| Enterprise Value to EBIT | -0.6 |
| Enterprise Value to Net Income | -354 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 18, 2026
EPS Estimate
$-0.22
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 21, 2026
EPS Estimate
$-0.25
Average shareholder expectationRevenue Estimate
$25,000
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data